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Abstract
Introduction: The Westernization of the Mediterra-
nean lifestyle has led to a modification of certain dietary 
habits such as a decrease in the consumption of dietary 
fibre-rich foods. The impact of these changes on cardio-
vascular diseases (CVD) has been studied over the last 
few years and the effect of the different sources of fibre 
on cardiovascular risk parameters and coronary heart 
disease (CHD) continues to create controversy.
Objective: To evaluate the association between the 
source of dietary fibre and the prevalence of metabolic 
syndrome (MetS) and other cardiovascular risk factors 
in a Spanish working population.
Subjects and methods: The study was carried out in a 
sample of 1592 Spanish workers free of CVD (40-55 years 
old) within the Aragon Workers' Health Study (AWHS) 
cohort. Sociodemographic, anthropometric, clinical and 
biochemical data were collected. Fibre intake was asses-
sed by means of a validated 136-items semiquantitati-
ve food-frequency questionnaire. MetS was defined by 
using the modified National Cholesterol Education Pro-
gramme - Adult Treatment Panel III (NCEP- ATP III) 
definition.
Results: After adjusting for possible confounding fac-
tors, we found an inverse association between insoluble 
fibre intake and systolic and diastolic blood pressure, 
total cholesterol, triglycerides, apolipoprotein B100 and 
ratio TG/HDL. Soluble fibre was inversely associated 
with triglycerides and apolipoprotein B100. Furthermo-
re, prevalence of MetS was found to be lower (OR 0.62, 
95% CI: 0.40-0.96) in those participants in the highest 
quartile of insoluble fibre intake.
INGESTA DE FIBRA SOLUBLE E 
INSOLUBLE y FACTORES DE RIESGO DE 
SíNDROME METABóLICO y ENFERMEDAD 
CARDIOVASCULAR EN ADULTOS DE 
MEDIANA EDAD: LA COHORTE AWHS
Resumen 
Introducción: La occidentalización del estilo de vida 
mediterráneo ha dado lugar a una modificación de cier-
tos hábitos dietéticos, tales como una disminución en el 
consumo de alimentos ricos en fibra dietética. El impac-
to de estos cambios sobre las enfermedades cardiovascu-
lares (ECV) se ha estudiado en los últimos años y el efec-
to de las diferentes fuentes de fibra en los parámetros 
de riesgo cardiovascular y en la enfermedad coronaria 
sigue creando controversia.
Objetivo: Evaluar la asociación entre la fuente de fi-
bra dietética y la prevalencia de síndrome metabólico 
(SM) y otros factores de riesgo cardiovascular en una 
población laboral española.
Sujetos y métodos: El estudio se llevó a cabo en una 
muestra de 1592 trabajadores españoles libres de ECV  
(40-55 años) pertenecientes a la cohorte del Estudio de 
la Salud de los Trabajadores de Aragón (AWHS). Se re-
cogieron datos sociodemográficos, antropométricos, clí-
nicos y bioquímicos. La ingesta de fibra se evaluó por 
medio de un cuestionario semicuantitativo de frecuencia 
de consumo de alimentos de 136-items previamente vali-
dado. Para la definición de SM se siguieron los criterios 
del Programa Nacional de Educación del Colesterol en el 
marco del III Panel de Tratamiento de Adultos (NCEP- 
ATP III).
Resultados: Se encontró una asociación inversa en-
tre el consumo de fibra insoluble y la presión arterial 
sistólica y diastólica, colesterol total, triglicéridos, apo-
lipoproteína B100 y la relación TG/HDL, tras ajustar 
por posibles factores de confusión. Así mismo, la fibra 
soluble se asoció inversamente con triglicéridos y apoli-
poproteína B100. Además, se encontró una menor pre-
valencia de  SM (OR 0.62, IC del 95%: 0.40 a 0.96) en 
aquellos participantes en el cuartil más alto de consumo 
de fibra insoluble.
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Conclusión: Una mayor ingesta de fibra insoluble 
puede desempeñar un papel importante en el control y 
manejo de la hipertensión, el perfil lipídico y el SM. 
(Nutr Hosp. 2014;30:1279-1288)
DOI:10.3305/nh.2014.30.6.7778
Palabras clave: Fibra dietética. Síndrome metabólico. En-
fermedad cardiovascular.
Conclusion: A higher intake of insoluble fibre could 
play an important role in the control and management of 
hypertension, lipid profile and MetS.
(Nutr Hosp. 2014;30:1279-1288)
DOI:10.3305/nh.2014.30.6.7778
Key words: Dietary fibre. Metabolic syndrome. Cardio-
vascular disease.
Abbreviations
CVD: Cardiovascular disease.
CHD: Coronary heart disease.
MetS: Metabolic syndrome.
AWHS: Aragon Workers´ Health Study.
SFFQ: Semiquantitative food-frequency questionnaire.
CRP: C reactive protein.
HbA1c: Glycated hemoglobin. 
MET: Metabolic equivalent.
NCEP-ATP III: National Cholesterol Education 
Programme - Adult Treatment Panel III.
IQR: Interquartile Range.
Introduction
The Westernization of the Mediterranean countries, 
has led to a decrease in the consumption of traditional 
Mediterranean foods concurrent with an increase in the 
prevalence of some chronic disorders such as cancer, 
obesity and cardiovascular diseases (CVD)1. Defined as 
a plant-derived material that is resistant to digestion by 
human alimentary enzymes2, dietary fibre consists main-
ly of polysaccharides and lignin, but also includes other 
vegetable substances such as waxes and cutin. Based on 
their physical properties of solubility, dietary fibre can be 
classified in two major groups: insoluble fibre, mainly 
present in wheat bran and whole bread and grains, and 
soluble fibre that is abundant in cereals such as oats and 
barley, legumes and most fruits and vegetables.
The role of dietary fibre-rich diets and the different 
dietary fibre sources in the prevention of CVD has been 
under investigation over the last few decades3. Dietary 
fibre seems to be related to a hypocholesterolemic effect 
and possibly also to the modulation of metabolic routes 
related to blood pressure4, blood glucose levels4, plate-
let aggregation5, endothelial damage5 or inflammation6. 
An insufficient intake of dietary fibre is also a known 
risk factor for the development of coronary heart disea-
se (CHD)7 and the source of dietary fibre is an impor-
tant factor in the modulation of this risk. Observational 
studies have found stronger associations for cereal fibre 
(mostly insoluble fibre) than for fibre deriving from fruits 
or vegetables in terms of lower incidence of CHD8,9. 
This study aims to investigate the association between 
the intake of different types of dietary fibre and the preva-
lence of metabolic syndrome (MetS) and other metabo-
lic-related conditions as intermediate markers of CVD in 
a cohort of Spanish workers.
Subjects and methods
Study participants
The Aragon Workers’ Health Study (AWHS) is a lon-
gitudinal prospective cohort study based on the annual 
health exams of voluntary workers of the General Mo-
tors Spain automobile assembly plant located in Figue-
ruelas (Zaragoza, Spain) with the aim to characterize 
the factors associated with metabolic abnormalities and 
subclinical atherosclerosis in a middle aged population 
free of clinical CVD. A detailed description of the co-
hort assembly procedures, and variables and outcomes 
studied has been reported previously10. 
Each year, one random third of study participants 40 
– 55 years of age at baseline are randomly selected for 
subclinical atherosclerosis imaging and for additional 
questionnaires of cardiovascular and lifestyle factors. 
The present cross-sectional analysis was carried out 
on a subsample of the first 1592 volunteers who com-
plete the semiquantitave food frequency questionnaire 
(SFFQ). The AWHS was approved by the Central Insti-
tutional Review Board of Aragón, and all study partici-
pants provided written informed consent.
Anthropometric, clinical and biological data
Study participants provided a clinical history, inclu-
ding clinical events and hospitalizations over the past 
year, indicating the presence of personal or family his-
tory of early CVD, diagnosis of hypertension, diabetes 
or dyslipidemia, current medication use and smoking 
status (current, never and former), and undergo a physi-
cal exam, including anthropometry (height, weight, and 
waist circumference), blood pressure measurements and 
heart rate. 
Each participant also provided a sample of blood af-
ter overnight fasting (>8 h) for laboratory analyses and 
biobanking. A battery of laboratory tests was performed 
annually in all workers at the laboratory of the Medi-
cal Services of General Motors Spain. Fasting serum 
glucose, triglycerides, total cholesterol and HDL cho-
lesterol were measured by spectrophotometry (Chemi-
cal Analyzer ILAB 650, Instrumentation Laboratory), 
serum apolipoproteins A1 and B100, lipoprotein (a) 
and C-reactive protein (CRP) by kinetic nephelometry 
(Immunochemistry Analyzer IMMAGE 800, Beckman 
Coulter), and fasting serum insulin by immunoenzyma-
tic chemiluminiscence (Access Immunoassay System, 
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Beckman Coulter). Whole blood glycated hemoglobin 
(HbA1c) was measured by reverse-phase cationic ex-
change chromatography and quantification by dou-
ble wave-length colorimetry quantification (Analyzer 
ADAMS A1c HA-810, Arkray Factory). LDL choleste-
rol levels were calculated using the Friedewald equation 
when triglycerides levels were lower than 400 mg/dl.
Dietary assessment
Dietary habits were assessed by means of a semi-
quantitative food-frequency questionnaire previously 
validated in Spain11, capturing long-term intake du-
ring the preceding year, taking into account seaso-
nal variations and differences between weekday and 
weekend patterns. The questionnaire is based on 136 
food items, including questions about consumption of 
supplements and special diets tracking. For each food 
included in the questionnaire serving size is specified 
and offer the choice between nine frequencies of con-
sumption, from “never or almost never” to “more than 
six times a day”. Data derived from the questionnaire 
were subsequently converted into energy and nutrients 
according to two Spanish food composition tables12,13. 
Physical activity assessment
For physical activity assessment we used the Spanish 
validated version of the Nurses’ Health Study and Health 
Professionals’ Follow-up physical activity questionnai-
res14. Participants were asked about the time devoted to 
the practice of 17 different sports during the year prece-
ding the date of the interview. It consists of 10 categories, 
from “never” to “more than 11 hours a week”. Partici-
pants were also asked about the months a year in which 
each activity was performed. To compute the volume of 
activity performed for each participant, metabolic equi-
valents (METs) were assigned for each activity15 and 
multiplied by the time the participant reported practicing 
each activity. From the sum of all activities we obtained a 
value of overall weekly METs-h.
Additional variables
Participants completed an additional questionnaire on 
sociodemographic characteristics including: date of birth, 
gender, education level, years in company, shift and type 
of work performed, marital status, number of children 
and number of people that integrate their family unit. 
Metabolic syndrome definition
MetS was diagnosed when subjects meet at least 3 
of the 5 following criteria: elevated waist circumferen-
ce (waist circumference ≥ 102 cm for men and ≥ 88 for 
women), elevated triglycerides (≥ 150 mg/dl or being 
on drug treatment for increased triglycerides), reduced 
HDL cholesterol (< 40 mg/dl for men and < 50 mg/dl 
for women), elevated blood pressure (systolic blood 
pressure ≥ 130 mmHg and/or diastolic blood pres-
sure ≥ 85 mmHg or being on antihypertensive drug 
treatment in a patient with a history of hypertension), 
and elevated fasting glucose (≥ 100 mg/dl or being on 
drug treatment for elevated glucose), according to the 
modified National Cholesterol Education Programme 
- Adult Treatment Panel III (NCEP-ATP III) defini-
tion16.
Statistical methods
Median and Interquartile Range (IQR) were used to 
describe participant’s characteristics. Differences in fi-
bre consumption between groups were analysed by the 
nonparametric Mann Whitney U-test for gender and 
type of work and by Kruskal-Wallis H-test for age, le-
vel of studies completed, shift work, smoking status and 
physical activity. Multivariate analysis was performed 
using multivariate linear models. Dependent variables 
were each of the clinical variables described, and inde-
pendent variables were intakes of both insoluble and 
soluble fibre. Results are presented as crude and adjus-
ted models using age, gender, energy intake (kcal/day), 
physical activity (METs-h/week), smoking status, al-
cohol (g/week), and treatment for hypertension, hyper-
cholesterolemia, and diabetes diagnosis as covariates. 
Logistic regression models were used for the analysis 
of the association between the intake of insoluble and 
soluble fibre and the prevalence of MetS and its compo-
nents. The discriminatory power was assessed using the 
area under the ROC curve (receiver-operator characte-
ristics) obtained by analysing the probability of the va-
lue predicted by the multivariate model. The results of 
the multivariable model were adjusted by age, gender, 
level of studies completed and type of work performed 
(Model A) and additionally adjusted for energy intake 
(kcal/day), physical activity (METs-h/week), smoking 
status and alcohol consumption (g/week) (Model B). 
All statistical analyses were conducted using STATA 
9.0/SE (Stata Corp, College Station, Tex) and p<0.05 
was considered statistically significant for all analysis. 
Results
Total mean dietary fibre intake was 25.7 ± 8.1 g/day 
corresponding mainly (70.4%) to insoluble fibre. The 
most important food sources of insoluble fibre intake 
were dried fruits (30%), whole grain breakfast cereals 
(11%), white beans (9.2%), nuts (7.8%), whole-wheat 
bread (6.8%) and green peas (6.1%), whereas soluble 
fibre intake was determined by the consumption of 
mostly dried fruits (8.5%), walnuts (4.5%) and nuts 
(2.0%).
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Total, insoluble and soluble fibre intake according 
to sociodemographic characteristics are presented in 
Table I. No significant differences were found by age, 
gender, level of studies completed or smoking status. 
Total, insoluble and soluble fibre intake were associa-
ted with increasing levels of physical activity, but only 
total and soluble fibre also seems to vary according to 
the type of work and shift of the participants.
Table II shows the crude and adjusted models for the 
association between insoluble and soluble fibre intake 
and each of the metabolic risk markers studied. We ob-
served an association between both insoluble and so-
luble fibre and BMI in the crude model, although the 
association disappeared after controlling for other va-
riables. Insoluble fibre was inversely associated with 
systolic blood pressure (β = -0.150; p = 0.032), and 
diastolic blood pressure (β = -0.125; p = 0.008) after 
adjusting for potential confounders. As for plasma lipids, 
insoluble fibre was again inversely associated with total 
cholesterol (β = -0.355; p = 0.042), triglycerides (β = 
-1.578; p = 0.001), and apolipoprotein B100 (β = -0.223; 
p = 0.049). Soluble fibre was inversely associated with 
triglycerides (β = -2.876; p = 0.041) and apolipoprotein 
B100 (β = -0.684; p = 0.047). This analysis indicates that 
increasing 1g/day of insoluble fibre is associated with a 
reduction of 0.037 mg/dl in the TG/HDL ratio, but no 
association was found for soluble fibre. 
The association between fibre intake and MetS and 
its definition criteria is shown in table III and IV. Data 
is presented for types of fibre. In the crude model we 
observed significant differences for MetS diagnosis and 
blood pressure, waist circumference, HDL cholesterol 
and fasting blood glucose criteria, on the highest quar-
tile of insoluble fibre intake. However, for soluble fibre, 
only significant differences were found for MetS diag-
nosis and waist circumference criterion. Model A, was 
adjusted for age, gender, level of studies completed and 
type of work. This adjustment affected the association 
between HDL cholesterol criterion and insoluble fibre 
as well as MetS diagnosis and soluble fibre intake. Mo-
del B was further adjusted for energy intake, physical 
activity, smoking status and alcohol. With respect to in-
soluble fibre, prevalence of MetS was found to be lower 
(OR 0.62, 95% CI: 0.40-0.96) in those participants in the 
highest quartile while no association were found for so-
luble fibre intake.
Discussion 
The present study shows the association of different 
sources of dietary fibre and the prevalence of MetS as 
well as different parameters of CVD, in a mostly male 
middle-aged population of Spanish workers. Neverthe-
less, we didn´t want to exclude women with the aim to 
adjust for gender and then obtain more generalizable 
and extrapolable results for being compared with other 
studies. Total amount of fibre intake found in this study 
agrees with the European Food Safety Authority (EFSA) 
Panel on Dietetic Products Nutrition, and Allergies 
(NDA) and the Spanish Society of Community Nutrition 
(SENC) recommendations for the Spanish population 
established in 25.0 g/day. Likewise, a similar intake has 
been reported in other epidemiological Spanish cohort 
studies, such as the SUN cohort follow-up17, the PREDI-
MED study18 and in the Spanish European Prospective 
Investigation into Cancer and Nutrition (EPIC) cohort 
study19. 
Although the AWHS study carries a rigorous gene-
ral protocol applied to the quality of each clinical and 
biochemical technique and dietary intake assessment in-
cludes personal interviews by trained interviewers, the 
use of SFFQ is unlikely to be quantitatively precise20. 
However this is not a lack of validity due to the fact that 
the measurement error used to be concentrate in the mi-
ddle categories and in epidemiological studies we tend to 
compare extremes21. 
Higher dietary fibre intake is associated with lower 
rates of obesity, which have been hypothesized to be re-
lated to a satiating effect of fibre which contributes to a 
subsequent decreased appetite22. This, however, usually 
depends on the type of fibre and can vary depending on 
whether fibre is from natural foods or supplements. The 
association between a higher practise of physical activi-
ty and soluble and insoluble fibre shows a healthy trend 
also seen in other studies23.
Elevated blood pressure is a known risk factor for 
CVD, but the pathophysiological mechanisms involved 
in its relationship with fibre intake are unclear. In our 
study, insoluble fibre was inversely associated with both 
systolic and diastolic blood pressure. This effect was 
also observed in a cohort of 5880 Spanish university 
graduates, where cereal fibre was inversely associated 
with the risk of hypertension17. A similar association was 
found in a cohort of 5961 French adults where those with 
higher insoluble fibre intake had a significant lower risk 
of high blood pressure24. Moreover, a randomized con-
trolled trial carried out in a sample of middle age healthy 
individuals found that the consumption of three servings 
of whole grain foods could significantly reduce the risk 
of CVD through the control of blood pressure mechanis-
ms25. It has been postulated that the hypotensive effects 
of dietary fibre could be related with the presence of an-
tioxidant or mineral compounds that may influence the 
production of regulators of vascular tone26. 
The association between a healthy dietary pattern and 
an optimal plasma lipid profile has been largely proven. 
The mechanisms of the changes in levels of plasma li-
pids are diverse, but most are related to healthy lifestyle 
habits such as the intake of dietary fibre-rich foods27. In 
the most widely accepted hypothesis, soluble fibre is as-
sociated with decreased levels of total and LDL choles-
terol and triglycerides through a direct mechanism of in-
creased bile acids and total cholesterol faecal excretion28 
that, subsequently, stimulates hepatic LDL cholesterol 
uptake thus reducing its concentration in plasma4. In fact, 
although no association was found in the crude model, 
once adjusted, the analysis showed that an increase of 
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1g/day of soluble fibre was associated with a reduction 
of 2.87 mg/dl of blood triglyceride levels. The associa-
tion with insoluble fibre was significant but lower with a 
reduction of 1.57 mg/dl for each gram of fibre increase. 
There was no association between any sort of fibre and 
LDL cholesterol. However, apart from LDL concentra-
tion, some LDL modifications such as oxidation play an 
important role in the atherogenic capacity of these parti-
cles29, and it has been postulated that the intake of some 
natural foods rich in antioxidants and polyphenols could 
provide antioxidant protection against LDL oxidation30. 
For this reason it has been proposed the use of apolipo-
protein B100 as better predictor of CHD31. 
The TG/HDL ratio has been identified as an indica-
tor of insulin resistance32 and it has been even shown 
its usefulness to predict a first coronary event in active 
men workers independently of obesity33, although its re-
lationship to fibre intake has not been fully investigated. 
Moreover, we did not observe any association between 
fibre intake and other insulin resistance parameters, con-
trary to a recent cross-sectional study carried out in 264 
women34 were especially soluble fibre consumption was 
significantly related with lower level of insulin resistance.
The MetS is the result of specific metabolic abnorma-
lities prevalent mainly in obese and overweight subjects, 
however is also present, although with less prevalence, in 
normoweight population. The prevalence of this syndro-
me in our sample (23.9% in men and 12.8% in women) 
was considerably higher than in other cohort studies ba-
sed on healthy Spanish workers like the MESYAS (ME-
tabolic SYndrome in Active Subjects) Registry35 (22% 
in men and 6.5% in women), probably due to a change 
in the threshold diagnosis of fasting blood glucose, from 
110 to 100 mg/dl. Although the pathogenesis of the MetS 
is not fully elucidated, it is known that there is a genetic 
predisposition on which environmental factors, mainly 
the dietary pattern, contribute to the development of this 
disorder. This group of risk factors is important, due to 
the fact that doubles the risk of ischemic heart disease 
and is also a good predictor of diabetes, so that, its clini-
cal utility seems to be presumable36. Nowadays, althou-
gh there is no any specific pharmacologic treatment for 
this syndrome, changes in lifestyle habits, such as an in-
creased physical activity and following a Mediterranean 
dietary pattern rich in fibre have been postulated as basic 
pillars in the treatment. In our study, we found a possible 
protective effect of insoluble dietary fibre intake based 
on the decreased risk of having MetS while no effect has 
been shown for soluble one. 
The results derived from this study are in line with 
a recent meta-analysis, where an increase of insoluble 
fibre intake was related with a lower risk of CVD and 
CHD3, whereas, another recently published meta-analy-
sis showed a significant dose-response relationship be-
tween fibre intake and CHD especially from that derived 
from cereals and fruits7, that is why further evidence is 
needed in order to establish what source of fibre involves 
more benefits, since so far, the results are still contradic-
tory. 
Conclusions
CVD are an important problem of public health due 
to the high prevalence in general population, where the 
prevention and treatment should be directed towards im-
proving a healthy lifestyle. Our study supports the idea 
that a diet rich in sources of insoluble fibre could play 
an important role in the prevention and management of 
hypertension, lipid profile and MetS.
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